PulseAugur
EN
LIVE 22:13:35

FDA Commissioner Marty Makary Resigns Amidst Controversy and Upheaval

By PulseAugur Editorial · [4 sources] ·

FDA Commissioner Dr. Marty Makary has resigned after a turbulent 13-month tenure marked by organizational upheaval and controversies. His initiatives to streamline drug approvals and increase transparency faced criticism for potentially overriding scientific principles with political interests. The agency experienced significant staff turnover and leadership changes, creating uncertainty about the future of Makary's policy changes and the confirmation of his successor. AI

IMPACT Unclear if AI was used in drug evaluations; Makary's departure creates uncertainty for regulatory streamlining efforts.

RANK_REASON Resignation of a high-profile government agency head after a controversial tenure. [lever_c_demoted from significant: ic=4 ai=0.4]

Read on Forbes — Innovation →

AI-generated summary · Google Gemini · from 4 sources. How we write summaries →

FDA Commissioner Marty Makary Resigns Amidst Controversy and Upheaval

How we ranked this

Signal score
0 / 100
Composite score across the factors below. Higher = stronger signal that this story matters right now.
Newsworthiness bucket
Research
Resignation of a high-profile government agency head after a controversial tenure. [lever_c_demoted from significant: ic=4 ai=0.4]
Source corroboration
4 independent sources
Strong cross-source corroboration — multiple independent publishers covered this within the clustering window.
Topics
policy, other
Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.
AI-industry relevance
Standard
On-topic for AI-industry coverage; kept in the public index.
Story freshness
137 days old
Aged out of breaking-news scoring windows; ranking reflects the durable signal from the full source set.

Full methodology in our editorial standards.

COVERAGE [4]

  1. Forbes — Innovation TIER_1 English(EN) · Joshua P. Cohen, Senior Contributor ·

    Unclear How FDA Commissioner Makary’s Departure Will Impact His Initiatives

    During a tumultuous 13-month tenure at the FDA, Makary pursued a wide range of ambitious initiatives. Going forward, their status under the next commissioner is unclear.

  2. Fortune TIER_1 English(EN) · The Associated Press, Matthew Perrone ·

    FDA Commissioner Dr. Marty Makary announced his resignation after a rocky year

    He's lasted longer than some previous heads, including one that announced his retirement after just three weeks on the job.

  3. Axios Technology TIER_1 English(EN) · Adriel Bettelheim ·

    Makary's exit creates new uncertainty at FDA

    <p>Marty Makary's <a href="https://www.axios.com/2026/05/12/makary-out-fda-chief-turmoil" target="_blank">departure</a> from the Food and Drug Administration may remove one of the Trump administration's lightning rods for controversy.</p><ul><li>But it won't solve the organizatio…

  4. Axios Technology TIER_1 English(EN) · Peter Sullivan ·

    Marty Makary out as FDA chief

    <p>Food and Drug Administration Commissioner <a href="https://www.axios.com/2026/05/11/fda-cliffhanger-makary-trump-administration" target="_blank">Marty Makary</a> is stepping down after a turbulent 13-month term marked by organizational upheaval, controversies over drug approva…

RELATED ENTITIES

RELATED TOPICS